Alcohol, tobacco, and illegal drug use cause considerable morbidity and mortality, but good cross-national epidemiological data are limited. This paper describes such data from the first 17 countries participating in the World Health Organization's (WHO's) World Mental Health (WMH) Survey Initiative.
Following the call at the AIDS High Level Meeting in New York for more effective HIV prevention amongst injecting drug users, a group of NGOs initiated a sign on letter to senior UN officials pointing out the contradictions between the drive to tackle this problem, and the stigmatisation and marginalisation of drug users that is often part of UN-supported drug control activities.
On June 19, 2008, WOLA Senior Associate John_Walsh testified before Joint Economic Committee of the US Congress (chaired by Senator Jim Webb, Democrat of Virginia) on U.S. drug policy.
To provide our network and partners with concise information on the background to the UNGASS 10-year review, the IDPC has produced an Advocacy Guide that explains the structures, processes and issues involved.
As the process of reviewing the 10-year achievements of the global drug control system continues, the IDPC has been synthesising the wide range of publications and analysis from its members into brief advocacy notes that summarise our positions on the key issues in this review.
As the process of reviewing the 10-year achievements of the global drug control system continues, the IDPC has been synthesising the wide range of publications and analysis from its members into brief advocacy notes that summarise our positions on the key issues in this review.
These two briefings focus on the current domestic and international debates regarding the Bolivian government's defence of the indigenous practice of coca chewing.
This version has only minor changes from the previous version, distributed in April, and will be the final version of the advocacy guide. From now on, a series of IDPC updates on the UN Drug Policy Review will be produced, the first being scheduled for the end of July. The IDPC Advocacy Guide provides an update on the emerging process for the review of global policies on controlled drugs being conducted under the auspices of the United Nations.